NCT06887855 Enhancing Post-Stroke Dysphagia Rehabilitation
| NCT ID | NCT06887855 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hamad Medical Corporation |
| Condition | Dysphagia After Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-11-01 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of a combined swallowing intervention (Neuromuscular Electrical Stimulation (NMES) + Neuromuscular Taping (NMT) + swallowing exercises) on swallowing function and quality of life in post-stroke dysphagia patients. The main questions it aims to answer are: • Does the combination of swallowing exercises, NMES \& NMT have a greater improvement in dysphagia rehabilitation when compared to either NMES or NMT alone? Researchers will compare the effects of intervention between the three groups (NMES and swallowing exercises, NMT and swallowing exercises, and NMES with NMT and swallowing exercises). Participants will: * Receive a combined dysphagia rehabilitation comprised of swallowing exercises, Neuromuscular Electrical stimulation, and/or Neuromuscular Taping. * Visit the clinic once every 5 days a week for 10 therapy sessions. * Undergo baseline and post-intervention evaluation procedures.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 - 75 years old, * Diagnosed with swallowing disorders between one day and six months post-stroke, * Able to attend 10 therapy sessions, * Have never received any swallowing treatment before participating in this study. Exclusion Criteria: * Post-stroke patients with severe cognitive impairment, * Patients who have swallowing disorders due to other etiologies, * Patients who need traditional swallowing therapy other than Expiratory Muscle Strength Training (EMST) and Chin Tuck Against Resistance (CTAR). - Skin disorders in the submental area and anterior neck, * Medical conditions that may affect participation, * A defibrillator and use precision electrical biomedical devices (e.g. pacemaker, etc.).
Contact & Investigator
Ibrahim Mohammad Alayaseh, M.Sc. _ SLP
STUDY CHAIR
Hamad Medical Corporation
Frequently Asked Questions
Who can join the NCT06887855 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Dysphagia After Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887855 currently recruiting?
Yes, NCT06887855 is actively recruiting participants. Contact the research team at ialayaseh@hamad.qa for enrollment information.
Where is the NCT06887855 trial being conducted?
This trial is being conducted at Doha, Qatar.
Who is sponsoring the NCT06887855 clinical trial?
NCT06887855 is sponsored by Hamad Medical Corporation. The principal investigator is Ibrahim Mohammad Alayaseh, M.Sc. _ SLP at Hamad Medical Corporation. The trial plans to enroll 10 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.